First Genome Sequencing Clinical Trial For Triple Negative Cancer Points To New Treat

[News]

Initial results from an ongoing clinical trial, the first designed to examine the utility of whole-genome sequencing for triple negative breast cancer, were reported during the CRTC-AACR San Antonio Breast Cancer Symposium. The results indicate activation of targets not previously associated with triple negative disease and could point toward new treatment strategies...

More... (http://www.medicalnewstoday.com/releases/238928.php)